Resonant Capital Advisors LLC Raises Stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Resonant Capital Advisors LLC lifted its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 32.2% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 41,348 shares of the company’s stock after buying an additional 10,082 shares during the quarter. Resonant Capital Advisors LLC’s holdings in Intellia Therapeutics were worth $1,261,000 […]

Related Keywords

Canada ,James Basta ,Nasdaq ,Canaccord Genuity Group ,Metlife Investment Management ,Resonant Capital Advisors ,Goldman Sachs Group ,Blair William Co ,Intellia Therapeutics Inc ,Cibc World Market Inc ,Wolfe Research ,Intellia Therapeutics ,Free Report ,Capital Advisors ,Life Investment Management ,World Market ,Canada Pension Plan Investment Board ,Get Free Report ,Genuity Group ,Visit Holdingschannel ,Intellia Therapeutics Daily ,